Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Arlene Bardeguez"'
Autor:
Elizabeth Livingston, Nahida Chakhtoura, Kunjal Patel, Paige L. Williams, Russell B. Van Dyke, Deborah Kacanek, Sandra K. Burchett, Mitchell E. Geffner, Rhoda S. Sperling, Elaine J. Abrams, Gwendolyn B. Scott, Jennifer Jao, Arlene Bardeguez
Background Pregnancy outcomes of perinatally human immunodeficiency virus-infected women (PHIV) are poorly defined. Methods We compared preterm delivery and birth weight (BW) outcomes (low BW [LBW]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e34a32dc4b51724a146f349d0517736
https://europepmc.org/articles/PMC5849107/
https://europepmc.org/articles/PMC5849107/
Autor:
Jesus R. Alvarez, Arlene Bardeguez, Shauna F. Williams, Bart Holland, Joseph J. Apuzzio, Ulas Bozdogan
Publikováno v:
Advances in Infectious Diseases. :172-176
Objective: To compare preterm delivery (PTD) rates in HIV-infected patients on a protease inhibitor (PI)-based and a PI-sparing regimen. Study Design: This is a retrospective review of records of HIV-infected pregnant women between 2000 and 2007 at U
Publikováno v:
AIDS Research and Human Retroviruses. 28:265-269
Our study compares perinatal outcomes among HIV(+) versus HIV(-) advanced maternal aged (AMA) women. A retrospective cohort study of AMA deliveries from 2000 to 2009 was performed. HIV(+) (group A) women were compared to temporally matched HIV(-) (gr
Autor:
Kelecia Brown, Arlene Bardeguez
Publikováno v:
Postgraduate Obstetrics & Gynecology. 30:1-7
Autor:
Elizabeth Livingston, Alice Stek, Ruth Tuomala, Gwendolyn B. Scott, Arlene Bardeguez, Yanling Huo, Kunjal Patel, Susan B. Brogly, Jennifer S. Read
Publikováno v:
Obstetrics & Gynecology
Over the past 20 years, there has been tremendous progress in the reduction of mother-to-child transmission of HIV-1 in the United States and other countries. This decrease in mother-to-child transmission of HIV-1 is temporally related to an increase
Autor:
Susan B. Brogly, Elizabeth Livingston, Kunjal Patel, Ruth Tuomala, David Shapiro, Arlene Bardeguez, Alice Stek
Publikováno v:
The Journal of Infectious Diseases. 201:1035-1044
Conflicting results have been reported among studies of protease inhibitor (PI) use during pregnancy and preterm birth. Uncontrolled confounding by indication may explain some of the differences among studies.In total, 777 human immunodeficiency viru
Autor:
Mark E. Mayer, Kevin B. Weiss, Mark Liebow, Yul D. Ejnes, Judith A. Aberg, P. Preston Reynolds, Kenneth Musana, Christine Lubinski, M. Renee Zerehi, Baligh R. Yehia, Richard Elion, David A. Fleming, Jennifer Rainey, Molly Cooke, Patricia Emmanuel, Robert Gluckman, Kathleen Squires, Michael S. Saag, Arlene Bardeguez, Mark W. Purtle, Charles Cutler, David L. Bronson, J. Fred Ralston, Daniel R. Kuritzkes, Andrea Weddle, Lavanya Viswanathan
Publikováno v:
Clinical Infectious Diseases. 48:1335-1344
Christine Lubinski, Judith Aberg, Arlene D. Bardeguez, Richard Elion, Patricia Emmanuel, Daniel Kuritzkes, Michael Saag, Kathleen E. Squires, Andrea Weddle, Jennifer Rainey, M. Renee Zerehi, J. Fred Ralston, David A. Fleming, David Bronson, Molly Coo
Autor:
Heather Watts, Elizabeth Livingston, Grace A. McComsey, Arlene Bardeguez, Triin Umbleja, Laura Mazzoli Smith, Theodore B. Jones, Susan E. Cohn, Yang Yang
Publikováno v:
Obstetrics & Gynecology. 110:391-397
To evaluate the effect of protease inhibitors on lipid and lactate levels and gastrointestinal symptoms in pregnancy.Acquired Immunodeficiency Syndrome (AIDS) Clinical Trials Group (ACTG) A5084 was an observational cohort study of human immunodeficie
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 20:853-857
The objective of this study was to describe one center's five-year experience of the management of human immunodeficiency virus (HIV) positive gravidas with preterm premature rupture of the membranes (PPROM) not in labor ator=34 weeks of gestation.Th
Autor:
Michael Hughes, Elizabeth Livingston, Deborah Kacanek, Ruth Tuomala, Erin Leister, Arlene Bardeguez, Alice Stek, Ingrid T. Katz, David Shapiro
A high delivery maternal plasma HIV-1 RNA level (viral load [VL]) is a risk factor for mother-to-child transmission and poor maternal health.To identify factors associated with detectable VL at delivery despite initiation of highly active antiretrovi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f4c2799518927a626f60d55076a5c5
https://europepmc.org/articles/PMC4299931/
https://europepmc.org/articles/PMC4299931/